275 related articles for article (PubMed ID: 11477578)
1. Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer.
Kundu N; Yang Q; Dorsey R; Fulton AM
Int J Cancer; 2001 Sep; 93(5):681-6. PubMed ID: 11477578
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
Rozic JG; Chakraborty C; Lala PK
Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
[TBL] [Abstract][Full Text] [Related]
3. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.
Boyan BD; Lohmann CH; Sisk M; Liu Y; Sylvia VL; Cochran DL; Dean DD; Schwartz Z
J Biomed Mater Res; 2001 Jun; 55(3):350-9. PubMed ID: 11255188
[TBL] [Abstract][Full Text] [Related]
4. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
6. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells.
Hung WC; Chang HC; Pan MR; Lee TH; Chuang LY
Mol Pharmacol; 2000 Dec; 58(6):1398-403. PubMed ID: 11093779
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.
Harizi H; Juzan M; Grosset C; Rashedi M; Gualde N
Cell Immunol; 2001 Apr; 209(1):19-28. PubMed ID: 11414733
[TBL] [Abstract][Full Text] [Related]
9. Inducible cyclooxygenase may have anti-inflammatory properties.
Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
[TBL] [Abstract][Full Text] [Related]
10. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in hum an tracheal epithelial cells in vitro.
Walenga RW; Kester M; Coroneos E; Butcher S; Dwivedi R; Statt C
Prostaglandins; 1996 Nov; 52(5):341-59. PubMed ID: 8948503
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation.
Sanchez PL; Salgado LM; Ferreri NR; Escalante B
Hypertension; 1999 Oct; 34(4 Pt 2):848-53. PubMed ID: 10523372
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of ethanol on the expression of cyclo-oxygenase in cultured cortical astrocytes and neurons.
Luo J; Lindström CL; Donahue A; Miller MW
J Neurochem; 2001 Mar; 76(5):1354-63. PubMed ID: 11238720
[TBL] [Abstract][Full Text] [Related]
15. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line.
Ferguson S; Hébert RL; Laneuville O
J Am Soc Nephrol; 1999 Nov; 10(11):2261-71. PubMed ID: 10541284
[TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
Kundu N; Fulton AM
Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
[TBL] [Abstract][Full Text] [Related]
17. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
Zhong H; Willard M; Simons J
Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
19. Phorbol ester stimulates cyclooxygenase-2 expression and prostanoid production in cardiac myocytes.
Schuette R; LaPointe MC
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H719-25. PubMed ID: 10924071
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ
Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]